News & Perspective

Dec 28, 2007

Dec 28, 2007

New cases wane in Uganda's Ebola outbreak

(CIDRAP News) – A health official in Uganda said yesterday that the Ebola outbreak in the western part of the country is receding, though it's too soon to say the disease has been contained, according to media reports.

Dec 03, 2007

Dec 03, 2007

Newspaper says lobbying helped sink anthrax vaccine

(CIDRAP News) – Lobbying by the maker of the only US-licensed anthrax vaccine was a key factor in causing the federal government to cancel its big contract with VaxGen Inc. for a new anthrax vaccine that was expected to be safer, according to a report published yesterday by the Los Angeles Times.

Nov 08, 2007

Nov 08, 2007

HHS issues guide for using call centers in emergencies

(CIDRAP News) – The Department of Health and Human Services (HHS) recently released a guide to help communities retool their health-related call centers into systems for meeting the needs of the public in homes or shelters during emergencies such as a pandemic or bioterrorist attack.

Oct 31, 2007

Oct 31, 2007

GAO critiques anthrax vaccine procurement, management

(CIDRAP News) – The US government's attempt to add a next-generation anthrax vaccine to its stockpile failed because of a premature contract award, unrealistic expectations, and confusion about how the vaccine would be used, according to the Government Accountability Office (GAO), the investigative agency of Congress.

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Oct 03, 2007

Oct 03, 2007

Federal grants support new anthrax countermeasures

(CIDRAP News) – Two pharmaceutical companies recently announced they received federal biodefense grants totaling $21.5 million to support the development of products that could be used to counter an anthrax attack.

Elusys Therapeutics, based in Pine Brook, N.J, said in a Sep 25 statement that it had been awarded a $12 million contract to continue developing AnthrimTM, the company's late-stage anthrax treatment.

Sep 26, 2007

Sep 26, 2007

HHS orders 18 million doses of anthrax vaccine

(CIDRAP News) – The federal government has awarded a $400 million contract to Emergent BioSolutions for another 18.75 million doses of anthrax vaccine, with a bonus to be paid if the company wins approval for extending the vaccine's shelf life.

Sep 19, 2007

Sep 19, 2007

Biosafety lapses reported at 3 more Texas labs

(CIDRAP News) – Three University of Texas facilities have recently had laboratory accidents with dangerous pathogens, including the agents of anthrax, tularemia, and shigellosis, according to a statement yesterday from the Sunshine Project, a nonprofit group that monitors biodefense research safety.

Sep 14, 2007

Sep 14, 2007

Inhaled anthrax vaccine is said to work in animals

(CIDRAP News) – Researchers from the University of Michigan recently reported promising results in animal tests of an inhaled anthrax vaccine, offering hope for a vaccine that would cause fewer side effects and be easier to store and administer than the licensed vaccine.

Sep 10, 2007

Sep 10, 2007

Animal hides were likely cause of 2 anthrax cases

(CIDRAP News) – Two people from Danbury, Conn., were recently diagnosed with cutaneous anthrax infections, probably because of exposure to spores on untanned animal hides brought from Africa.

Pages

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»